The relationship between the severity of COVID-19, patient outcomes, and the values and dynamics of biomarkers such as leukocytes, neutrophil-to-lymphocyte ratio (NLR), CRP, ASAT, LDH, D-dimers, ferritin, and IL-6 has been demonstrated in numerous studies. This evidence concerns the gene IL6 and COVID-19.